Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence

M Maurer, M Metz, R Brehler, U Hillen, T Jakob… - Journal of allergy and …, 2018 - Elsevier
Background Omalizumab, a recombinant anti-IgE antibody, effectively treats chronic
spontaneous urticaria. Evidence is lacking in patients with chronic inducible urticarias …

Management of chronic urticaria in children: a clinical guideline

C Caffarelli, F Paravati, M El Hachem, M Duse… - Italian journal of …, 2019 - Springer
The aim of this guidance is to provide recommendations to clinicians and other interested
parties on chronic urticaria in children. The Italian Society for Pediatrics (SIP), the Italian …

The definition, diagnostic testing, and management of chronic inducible urticarias – The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and …

M Magerl, S Altrichter, E Borzova, A Giménez‐Arnau… - Allergy, 2016 - Wiley Online Library
These recommendations for the definition, diagnosis and management of chronic inducible
urticaria (CI ndU) extend, revise and update our previous consensus report on physical …

Visible light in photodermatology

S Narla, I Kohli, IH Hamzavi, HW Lim - Photochemical & Photobiological …, 2020 - Springer
Until recently, visible light (VL) had been regarded to be without significant photobiologic
effect on the skin. Updated research suggests that this is not the case and the measurable …

Anti-IgE for the treatment of chronic urticaria

B Wedi, S Traidl - ImmunoTargets and Therapy, 2021 - Taylor & Francis
Urticaria and angioedema are very common. Management of chronic urticaria subtypes,
which usually persist for many years, is challenging. Recent years have demonstrated that …

Review of physical urticarias and testing methods

M Sánchez-Borges, L González-Aveledo… - Current Allergy and …, 2017 - Springer
Abstract Purpose of Review This review aims to update the information available on the
prevalence, clinical picture, diagnostic methods, and treatment of urticarias induced by …

Omalizumab for the treatment of solar urticaria: case series and systematic review of the literature

I Snast, N Kremer, M Lapidoth, CD Enk, Y Tal… - The Journal of Allergy …, 2018 - Elsevier
Background Solar urticaria (SU) is a rare photodermatosis causing a significant impact on
patients' quality of life. Although the condition can be controlled with phototherapy and/or a …

Omalizumab for chronic urticaria in children younger than 12 years

T Al-Shaikhly, JA Rosenthal, AG Ayars… - Annals of Allergy …, 2019 - annallergy.org
Chronic urticaria (CU), defined by recurrent wheals, angioedema, or both lasting more than
6 weeks, is subclassified into chronic spontaneous urticaria (CSU) and inducible urticaria …

Ultraviolet radiation and skin mast cells: Effects, mechanisms and relevance for skin diseases

H Siiskonen, A Smorodchenko… - Experimental …, 2018 - Wiley Online Library
Mast cells (MC s) are well known as versatile effector cells in allergic reactions and several
other immune responses. Skin MC s and cutaneous MC responses are subject to the effects …

An overview of off-label use of humanized monoclonal antibodies in paediatrics

R Bernardini, G Toschi Vespasiani, A Giannetti - Medicina, 2022 - mdpi.com
In recent years, off-label and unlicensed drug use has extensively developed in the
paediatric population. For a long time, clinical trials in the paediatric population were …